Malek TR[au] - Search Results

Year	Number of Results
1974	2
1975	2
1977	1
1978	2
1981	2
1982	1
1983	4
1984	8
1985	10
1986	9
1987	1
1988	2
1989	3
1990	5
1992	1
1993	5
1994	4
1995	5
1996	2
1997	3
1998	3
1999	4
2000	7
2001	6
2002	4
2003	4
2004	3
2005	1
2006	4
2007	3
2008	5
2009	4
2010	4
2011	4
2012	4
2013	3
2014	6
2015	3
2016	3
2017	3
2018	3
2019	2
2020	4
2021	3
2022	3

1

The biology of interleukin-2.

Malek TR. Malek TR. Annu Rev Immunol. 2008;26:453-79. doi: 10.1146/annurev.immunol.26.021607.090357. Annu Rev Immunol. 2008. PMID: 18062768 Review.

2

Engineering IL-2 for immunotherapy of autoimmunity and cancer.

Hernandez R, Põder J, LaPorte KM, Malek TR. Hernandez R, et al. Among authors: malek tr. Nat Rev Immunol. 2022 Feb 25. doi: 10.1038/s41577-022-00680-w. Online ahead of print. Nat Rev Immunol. 2022. PMID: 35217787 Review.

3

Regulatory T cells in the treatment of disease.

Sharabi A, Tsokos MG, Ding Y, Malek TR, Klatzmann D, Tsokos GC. Sharabi A, et al. Among authors: malek tr. Nat Rev Drug Discov. 2018 Nov;17(11):823-844. doi: 10.1038/nrd.2018.148. Epub 2018 Oct 12. Nat Rev Drug Discov. 2018. PMID: 30310234 Review.

4

Cytokine Signaling in the Development and Homeostasis of Regulatory T cells.

Toomer KH, Malek TR. Toomer KH, et al. Among authors: malek tr. Cold Spring Harb Perspect Biol. 2018 Mar 1;10(3):a028597. doi: 10.1101/cshperspect.a028597. Cold Spring Harb Perspect Biol. 2018. PMID: 28620098 Free PMC article. Review.

5

Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2.

Dwyer CJ, Ward NC, Pugliese A, Malek TR. Dwyer CJ, et al. Among authors: malek tr. Curr Diab Rep. 2016 Jun;16(6):46. doi: 10.1007/s11892-016-0739-1. Curr Diab Rep. 2016. PMID: 27076179 Free PMC article. Review.

6

The importance of regulatory T-cell heterogeneity in maintaining self-tolerance.

Yuan X, Cheng G, Malek TR. Yuan X, et al. Among authors: malek tr. Immunol Rev. 2014 May;259(1):103-14. doi: 10.1111/imr.12163. Immunol Rev. 2014. PMID: 24712462 Free PMC article. Review.

7

Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

Malek TR, Castro I. Malek TR, et al. Immunity. 2010 Aug 27;33(2):153-65. doi: 10.1016/j.immuni.2010.08.004. Immunity. 2010. PMID: 20732639 Free PMC article. Review.

8

Tolerance, not immunity, crucially depends on IL-2.

Malek TR, Bayer AL. Malek TR, et al. Nat Rev Immunol. 2004 Sep;4(9):665-74. doi: 10.1038/nri1435. Nat Rev Immunol. 2004. PMID: 15343366 Review.

9

Medical Treatment Can Unintentionally Alter the Regulatory T-Cell Compartment in Patients with Widespread Pathophysiologic Conditions.

Copsel SN, Malek TR, Levy RB. Copsel SN, et al. Among authors: malek tr. Am J Pathol. 2020 Oct;190(10):2000-2012. doi: 10.1016/j.ajpath.2020.07.012. Epub 2020 Aug 1. Am J Pathol. 2020. PMID: 32745461 Free PMC article. Review.

10

Cellular and molecular determinants for the development of natural and induced regulatory T cells.

Yuan X, Malek TR. Yuan X, et al. Among authors: malek tr. Hum Immunol. 2012 Aug;73(8):773-82. doi: 10.1016/j.humimm.2012.05.010. Epub 2012 Jun 1. Hum Immunol. 2012. PMID: 22659217 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results